Metabolic Topography of Parkinsonism.
- Author:
Jae Seung KIM
1
Author Information
1. Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Korea. jaeskim@amc.seoul.kr
- Publication Type:Review
- Keywords:
Parkinsonism;
F-18 FDG;
PET;
Metabolism
- MeSH:
Aged;
Dementia;
Diagnosis;
Diagnosis, Differential;
Dopamine;
Ganglion Cysts;
Glucose;
Humans;
Lewy Bodies;
Metabolism;
Multiple System Atrophy;
Neurodegenerative Diseases;
Neurons;
Parkinson Disease;
Parkinsonian Disorders*;
Pathology;
Phenotype;
Prognosis;
Supranuclear Palsy, Progressive;
Synapses
- From:Nuclear Medicine and Molecular Imaging
2007;41(2):141-151
- CountryRepublic of Korea
- Language:English
-
Abstract:
Parkinson's disease is one of the most frequent neurodegenerative diseases, which mainly affects the elderly. Parkinson's disease is often difficult to differentiate from atypical parkinson diorder such as progressive supranuclear palsy, multiple system atrophy, dementia with Lewy body, and corticobasal ganglionic degeneration, based on the clinical findings because of the similarity of phenotypes and lack of diagnostic markers. The accurate diagnosis of Parkinson's disease and atypical Parkinson disorders is not only important for deciding on treatment regimens and providing prognosis, but also it is critical for studies designed to investigate etiology and pathogenesis of parkinsonism and to develop new therapeutic strategies. Although degeneration of the nigrostriatal dopamine system results in marked loss of striatal dopamine content in most of the diseases causing parkinsonism, pathologic studies revealed different topographies of the neuronal cell loss in Parkisonism. Since the regional cerebral glucose metabolism is a marker of integrated local synaptic activity and as such is sensitive to both direct neuronal/synaptic damage and secondary functional disruption at synapses distant from the primary site of pathology, an assessment of the regional cerebral glucose metabolism with F-18 FDG PET is useful in the differential diagnosis of parkinsonism and evaluating the pathophysiology of parkisonism.
